Medical Microbiology articles for Switzerland

Time frame: 1 July 2025 - 30 June 2026

View topic

Count: 68

Article ‘Count’ for Medical Microbiology.

Journal Count Share
2 0.50
A Novel Antimalarial Agent that Inhibits Protein Synthesis in Plasmodium falciparum 0.47
The ATM Kinase Inhibitor AZD0156 Is a Potent Inhibitor of iPlasmodium/i Phosphatidylinositol 4‐Kinase (PI4Kβ) and Is an Attractive Candidate for Medicinal Chemistry Optimization Against Malaria 0.03
1 0.18
The Incubation Periods of Mpox Virus Clade Ib. 0.18
1 0.40
Proinflammatory Epstein–Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis 0.40
3 0.39
Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections 0.06
Deltaviruses spread through a viral Trojan Horse 0.02
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation 0.31
1 0.11
Naturally acquired promoter variation influences Streptococcus pneumoniae infection outcomes 0.11
5 1.25
Adherence to Hepatocellular Carcinoma Surveillance Guidelines Among People with HIV and Chronic HBV Infection 0.03
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials 0.07
Diagnostic performance of the Pluslife MiniDock MTB and Molbio MTB Ultima assays to detect tuberculosis from tongue and sputum swabs among outpatients and in active case finding in Cameroon 0.08
Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIV 0.07
Impact of Discontinuation of Contact Precautions on Healthcare-associated ESBL-producing Escherichia coli in a Large Tertiary Care Hospital: An Interrupted Time-series Analysis 1.00
1 1.00
Antimicrobial resistance in wildlife: Associations with environmental factors and taxonomic variation 1.00
1 0.06
Synthesis and Biological Evaluation of Itraconazole Derivatives: Design in an Old Scaffold 0.06
1 0.25
Pharmacological targeting of the mycothiol cysteine ligase MshC in Mycobacterium abscessus 0.25
1 0.43
Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains 0.43
1 0.31
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells 0.31
5 1.62
Nosocomial outbreak of Lassa fever in Conakry, Guinea, 2022 0.07
Anti-spike IgG Avidity Enhances Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2: A Prospective Study of Primary Infections and Immunizations 0.05
Bacterial Meningitis Epidemiology in Burkina Faso and Niger - High-Risk Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2023 0.09
Epidemiological and Molecular Surveillance of Multiresistant Citrobacter freundii Complex in a Tertiary Care Hospital: A Retrospective Cohort Study 1.00
Diagnostic Performance and Kinetics of Hepatitis E Viral RNA and IgM Antibody Test Positivity in a Genotype 1 Outbreak in South Sudan 0.42
2 1.08
Photoswitchable RNA Degraders for Spatiotemporal Activation of Host-Directed Antivirals in Mammalian Cells 1.00
Targeting the SARS-CoV-2 RNA Translation Initiation Element SL1 by Molecules of Low Molecular Weight 0.08
4 1.00
Host control of persistent Epstein–Barr virus infection 0.00
Pre-assembly of biomolecular condensate seeds drives RSV replication 0.12
Potent neutralization of Marburg virus by a vaccine-elicited antibody 0.35
EBV induces CNS homing of B cells attracting inflammatory T cells 0.53
20 8.20
Effectiveness of the BALatrine intervention on soil-transmitted helminth infections in Central Java, Indonesia: a cluster-randomised controlled trial 0.04
Transferrin receptor 1 binds human parvovirus B19 VP1u to facilitate entry 0.56
Structure of ergosteryl-aspartate synthase reveals how an entrapped tRNA is used like a prosthetic swinging arm in the synthesis of aminoacylated sterols 0.10
Long-term spatiotemporal evolution of drug-resistant Mycobacterium tuberculosis in China 0.10
Stepwise firing mechanism of an extracellular contractile injection system 1.00
Alpibectir–Ethionamide combination (AlpE) for the treatment of tuberculosis 0.17
B cell immunity to the Lassa virus glycoprotein is a correlate of vaccination-induced virus control in mice 0.88
Collateral hypersensitivity between ZY19489 and piperaquine neutralizes PfCRT-mediated drug efflux and Plasmodium falciparum resistance 0.03
Mechanisms of PfDNMT2 inhibition and PfATP6-mediated resistance to the antimalarial candidate SC83288 in Plasmodium falciparum 0.03
Identification and structural characterization of anthrax toxin receptor 2 as the Clostridium perfringens NetF receptor 1.00
Efficacy of two rounds of albendazole treatment on soil-transmitted helminths in schoolchildren, Yunnan Province, China 0.06
Segmented filamentous bacteria undergo a structural transition at their adhesive tip during unicellular to filament development 0.20
LANA-specific CD4+ effector T cells accumulate at the site of KSHV infection in humanized mice 0.82
Mechanisms of Pseudomonas aeruginosa resistance to type VI secretion system attacks 1.00
CarbaDetector: a machine learning model for detecting carbapenemase-producing Enterobacterales from disk diffusion tests 0.22
Bioenergetic reprogramming of macrophages reduces drug tolerance in Mycobacterium tuberculosis 0.07
The bactericidal FabI inhibitor Debio 1453 clears antibiotic-resistant infection in vivo 0.61
Genome-wide antibiotic-CRISPRi profiling identifies LiaR activation as a strategy to resensitize fluoroquinolone-resistant 1.00
Distinct echinocandin responses of Candida albicans and Candida auris cell walls revealed by solid-state NMR 0.18
CRISPRi screen identifies FprB as a synergistic target for gallium therapy in Pseudomonas aeruginosa 0.13
1 0.03
Evaluation of antimicrobial resistance governance across 193 countries to inform the 2026 Global Action Plan update 0.03
1 0.08
TMPRSS2-mediated coronavirus spike activation and inhibition 0.08
1 0.04
Livestock antimicrobial use embodied in global supply chains 0.04
2 0.81
Computational design of an ultrapotent deltacoronavirus miniprotein inhibitor 0.27
A two-component system signaling hub controls enterococcal membrane remodeling in response to daptomycin 0.53
2 0.58
Dynamic shift in the dominant transmission route of clade Ib monkeypox virus across networks with sexual and nonsexual contacts 0.13
A pan-respiratory virus attachment inhibitor with high potency in human airway models and in vivo 0.45
4 0.31
Deep learning–enabled discovery of antibiotics effective against Neisseria gonorrhoeae 0.04
The pyrrolidinamide antimalarial drug MMV367 rapidly clears blood-stage Plasmodium falciparum in healthy adults with experimental malaria 0.17
Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesions 0.03
Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with Plasmodium falciparum 0.07
1 0.35
Structure and function of a fungal AB toxin-like chimerolectin involved in anti-nematode defense 0.35
1 0.57
Thermophilic bacteria employ a contractile injection system in hot spring microbial mats 0.57
3 0.35
Impact of introducing RTS,S/AS01E malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme 0.13
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial 0.16
Epidemiology and phylogenomic characterisation of two distinct mpox outbreaks in Kinshasa, DR Congo, involving a new subclade Ia lineage: a retrospective, observational study 0.05
2 0.22
WHO estimates of the global, regional, and national foodborne burdens of 14 invasive parasitic diseases, 2000–21: an updated data synthesis 0.18
Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 study 0.04
1 0.06
Marburg Virus Disease in Rwanda, 2024 — Public Health and Clinical Responses 0.06

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.